Contact this trialFirst, we need to learn more about you.
PD-L1 Inhibitor
Durvalumab + Radiation Therapy for Lung Cancer
Recruiting1 awardPhase 2
Basking Ridge, New Jersey
This trial is testing whether Durvalumab and radiation therapy can improve outcomes for patients with non-small cell lung cancer, compared to the standard sequential chemotherapy and radiation therapy.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.